HMI-202: Investigational Gene Therapy for Treatment of Metachromatic Leukodystrophy HMI-202: Investigational Gene Therapy for Treatment of Metachromatic Leukodystrophy Gingras J, St-Martin T, Gall K, et al. WORLDSymposium 2020.